Two studies published recently in medical journals found devastating news for most the world.<br />Anti-malaria medication hydroxychloroquine failed to help hospitalized coronavirus patients.<br />The studies, both observational, looked at the outcomes of more than 2,000 patients.<br />The patients were hospitalized coronavirus victims in New York, reports Business Insider.<br />Hydroxychloroquine got attention early on in the pandemic as a potential treatment for COVID-19.<br />It has not been approved by the FDA for the treatment of COVID-19.
